vs
Acadia Healthcare Company, Inc.（ACHC）与PLEXUS CORP（PLXS）财务数据对比。点击上方公司名可切换其他公司
PLEXUS CORP的季度营收约是Acadia Healthcare Company, Inc.的1.4倍（$1.2B vs $829.0M），PLEXUS CORP净利率更高（4.3% vs 0.5%，领先3.7%），PLEXUS CORP同比增速更快（18.7% vs 7.5%），过去两年PLEXUS CORP的营收复合增速更高（7.2% vs 2.0%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
Plexus Corp是总部位于美国密歇根州特洛伊市的软件企业，专注于开发及推广Plex制造云产品，这是一款面向制造行业的SaaS模式云计算ERP解决方案，可助力制造企业实现数字化运营管理升级。
ACHC vs PLXS — 直观对比
营收规模更大
PLXS
是对方的1.4倍
$829.0M
营收增速更快
PLXS
高出11.2%
7.5%
净利率更高
PLXS
高出3.7%
0.5%
两年增速更快
PLXS
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.2B |
| 净利润 | $4.5M | $49.8M |
| 毛利率 | — | 10.2% |
| 营业利润率 | — | 5.3% |
| 净利率 | 0.5% | 4.3% |
| 营收同比 | 7.5% | 18.7% |
| 净利润同比 | -50.8% | 27.5% |
| 每股收益（稀释后） | $0.05 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCPLXS
| Q2 26 | — | $1.2B | ||
| Q1 26 | $829.0M | $1.1B | ||
| Q4 25 | $821.5M | — | ||
| Q3 25 | $851.6M | — | ||
| Q2 25 | $869.2M | — | ||
| Q1 25 | $770.5M | — | ||
| Q4 24 | $774.2M | — | ||
| Q3 24 | $815.6M | — |
净利润ACHCPLXS
| Q2 26 | — | $49.8M | ||
| Q1 26 | $4.5M | $41.2M | ||
| Q4 25 | $-1.2B | — | ||
| Q3 25 | $36.2M | — | ||
| Q2 25 | $30.1M | — | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $68.1M | — |
毛利率ACHCPLXS
| Q2 26 | — | 10.2% | ||
| Q1 26 | — | 9.9% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — |
营业利润率ACHCPLXS
| Q2 26 | — | 5.3% | ||
| Q1 26 | — | 5.1% | ||
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 12.1% | — |
净利率ACHCPLXS
| Q2 26 | — | 4.3% | ||
| Q1 26 | 0.5% | 3.8% | ||
| Q4 25 | -143.3% | — | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 8.4% | — |
每股收益（稀释后）ACHCPLXS
| Q2 26 | — | $1.82 | ||
| Q1 26 | $0.05 | $1.51 | ||
| Q4 25 | $-12.98 | — | ||
| Q3 25 | $0.40 | — | ||
| Q2 25 | $0.33 | — | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.74 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $303.1M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.0B | $1.5B |
| 总资产 | $5.5B | $3.4B |
| 负债/权益比越低杠杆越低 | 1.29× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCPLXS
| Q2 26 | — | $303.1M | ||
| Q1 26 | $158.5M | $248.8M | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | — |
总债务ACHCPLXS
| Q2 26 | — | — | ||
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — |
股东权益ACHCPLXS
| Q2 26 | — | $1.5B | ||
| Q1 26 | $2.0B | $1.5B | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $3.1B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.0B | — |
总资产ACHCPLXS
| Q2 26 | — | $3.4B | ||
| Q1 26 | $5.5B | $3.2B | ||
| Q4 25 | $5.5B | — | ||
| Q3 25 | $6.4B | — | ||
| Q2 25 | $6.3B | — | ||
| Q1 25 | $6.1B | — | ||
| Q4 24 | $6.0B | — | ||
| Q3 24 | $5.9B | — |
负债/权益比ACHCPLXS
| Q2 26 | — | — | ||
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 13.78× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACHCPLXS
| Q2 26 | — | — | ||
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | — | ||
| Q3 25 | $73.2M | — | ||
| Q2 25 | $133.5M | — | ||
| Q1 25 | $11.5M | — | ||
| Q4 24 | $116.7M | — | ||
| Q3 24 | $163.1M | — |
自由现金流ACHCPLXS
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — |
自由现金流率ACHCPLXS
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — |
资本支出强度ACHCPLXS
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — |
现金转化率ACHCPLXS
| Q2 26 | — | — | ||
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | — | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
PLXS
| Asia-Pacific | $652.0M | 56% |
| Americas | $397.0M | 34% |
| Europe, Middle East and Africa | $116.0M | 10% |
